About Jamjoom Pharma
Jamjoom Pharma is a company based in Jeddah (Saudi Arabia) founded in 2000. Jamjoom Pharma offers products and services including Pharmaceuticals and Ophthalmology Products.
- Headquarter Jeddah, Saudi Arabia
- Stage Public
- SectorsHealthcare
- Website category Health · Pharmacy
- Email••••••••
- Phone•••• ••••
- Website jamjoompharma.com
- Social LinkedIn X YouTube
- Legal Name Jamjoom Pharmaceuticals Factory Co.
- Annual Revenue$1.5 B13.82as on Dec 31, 2025
- Net Profit$463.8 M30.09as on Dec 31, 2025
- EBITDA$504.12 M20.62as on Dec 31, 2025
Products & Services of Jamjoom Pharma
Jamjoom Pharma offers a comprehensive portfolio of products and services, including Pharmaceuticals and Ophthalmology Products.
Medicines are manufactured and distributed in various therapeutic categories, including Ophthalmology and Dermatology
Products are developed and supplied for eye care, focusing on high-quality standards
Apps and channels of Jamjoom Pharma
its YouTube channel Jamjoom Pharma has 18 subscribers.
People of Jamjoom Pharma
1 people are tracked at Jamjoom Pharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
Tarek Youssef Hosni | CEO | Leadership |
Complete people profiles for Jamjoom Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Jamjoom Pharma
Jamjoom Pharma is a publicly listed company on the TADAWUL with ticker symbol 4015 in Saudi Arabia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date20 Jun 2023
- Listed onTADAWUL: 4015
- Listed entityJamjoom Pharmaceuticals Factory Co.
- Exchange sectorHealth technology
- ISINSA15QGU1UNH6
- Share price124.40 SAR (-0.8% on the day) · 2026-10-12
- Market capitalisation8,960,000,000.00 SAR
- Price to earnings18.1
- EPS (diluted, trailing year)6.87 SAR
- Dividend yield3.28%
- Volume (last session)27,726
Financials of Jamjoom Pharma
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 1.50B SAR | 463.8M SAR | 504.1M SAR |
| 2024 | 1.32B SAR | 356.5M SAR | 417.9M SAR |
| 2023 | 1.10B SAR | 292.4M SAR | 343.1M SAR |
| 2022 | 916.7M SAR | 171.3M SAR | 256.6M SAR |
| 2021 | 735.7M SAR | 170.7M SAR | 208.7M SAR |
Detailed financial statements for Jamjoom Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Jamjoom Pharma
The website of Jamjoom Pharma (jamjoompharma.com) receives about 38.5K visits a month and ranks #975,898 among all websites worldwide, #1,669 in Pharmacy.
- Monthly visits38.5K
▲ 28.7% vs previous month
- Unique visitors13.9K
per month
- Global rank#975,898
among all websites
- Category rank#1,669
Health · Pharmacy
- Bounce rate40%
- Pages per visit1.8
- Average visit51 sec
- DevicesDesktop 24% · Mobile 76%
Websites whose visitors overlap most with Jamjoom Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
meppo.com | meppo.com | 100% | – | – | – |
pharmazone.com | pharmazone.com | 80% | – | #107,916 | – |
| spimaco.com.sa | 80% | 7K | #2,233,541 | View details | |
| medicalstore.com.pk | 80% | – | #218,977 | View details | |
| lgmpharma.com | 64% | 20.1K | #1,606,485 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for Jamjoom Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Jamjoom Pharma
10 companies that operate in the same segment as Jamjoom Pharma (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Jamjoom Pharma
Jamjoom Pharma was founded in 2000.
Jamjoom Pharma is headquartered in Jeddah, Saudi Arabia. It is registered at Jeddah, Makkah Region, Saudi Arabia.
Tarek Youssef Hosni is the current CEO of Jamjoom Pharma.
Jamjoom Pharma was established in 2000 and is based in Jeddah, Saudi Arabia. Operations focus on the production of pharmaceutical products such as tablets, capsules, drops, solutions, creams, and ointments. These items are developed for therapeutic areas including cardiovascular, dermatology, gastrointestinal, ophthalmology, general medicine, and nutritional supplements, serving the healthcare sector in the region.
Jamjoom Pharma offers Pharmaceuticals and Ophthalmology Products.
Yes, Jamjoom Pharma is publicly traded on TADAWUL under the ticker symbol 4015.
Jamjoom Pharma operates through Jamjoom Pharmaceuticals.